Given the labile and unstable nature of S-nitrosothiol modifications, ongoing efforts focus on collecting large quantities of fresh–frozen melanoma tumors for future biotin-switch assays and mass spectrometry-based detection of p53 SNO in clinical specimens. This evidence concerns the gene TP53 and melanoma.